Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Co-culture of human fibroblasts, smooth muscle and endothelial cells promotes osteopontin induction in hypoxia.

Sadaghianloo N, Contenti J, Dufies M, Parola J, Rouleau M, Lee S, Peyron JF, Fabbri L, Hassen-Khodja R, Pouysségur J, Bost F, Jean-Baptiste E, Dardik A, Mazure NM.

J Cell Mol Med. 2020 Feb 7. doi: 10.1111/jcmm.14905. [Epub ahead of print]

2.
3.

GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism.

Mondragón L, Mhaidly R, De Donatis GM, Tosolini M, Dao P, Martin AR, Pons C, Chiche J, Jacquin M, Imbert V, Proïcs E, Boyer L, Doye A, Luciano F, Neels JG, Coutant F, Fabien N, Sormani L, Rubio-Patiño C, Bossowski JP, Muller F, Marchetti S, Villa E, Peyron JF, Gaulard P, Lemonnier F, Asnafi V, Genestier L, Benhida R, Fournié JJ, Passeron T, Ricci JE, Verhoeyen E.

Cancer Cell. 2019 Sep 16;36(3):268-287.e10. doi: 10.1016/j.ccell.2019.07.008. Epub 2019 Aug 22.

PMID:
31447347
4.

Withdrawal: Hepatitis C virus NS5A and subgenomic replicon activate NF- κ B via tyrosine phosphorylation of I κ B α and its degradation by calpain protease.

Waris G, Livolsi A, Imbert V, Peyron JF, Siddiqui A.

J Biol Chem. 2018 Dec 28;293(52):20012. doi: 10.1074/jbc.W118.007016. No abstract available.

5.

Metformin, an Anti-diabetic Drug to Target Leukemia.

Biondani G, Peyron JF.

Front Endocrinol (Lausanne). 2018 Aug 10;9:446. doi: 10.3389/fendo.2018.00446. eCollection 2018. Review.

6.

Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA.

Thongon N, Zucal C, D'Agostino VG, Tebaldi T, Ravera S, Zamporlini F, Piacente F, Moschoi R, Raffaelli N, Quattrone A, Nencioni A, Peyron JF, Provenzani A.

Cancer Metab. 2018 Mar 8;6:1. doi: 10.1186/s40170-018-0174-7. eCollection 2018.

7.

Mitochondrial Transfer in the Leukemia Microenvironment.

Griessinger E, Moschoi R, Biondani G, Peyron JF.

Trends Cancer. 2017 Dec;3(12):828-839. doi: 10.1016/j.trecan.2017.10.003. Epub 2017 Nov 6. Review.

PMID:
29198439
8.

Co-targeting intracellular pH and essential amino acid uptake cooperates to induce cell death of T-ALL/LL cells.

Imbert V, Nebout M, Mary D, Endou H, Wempe MF, Supuran CT, Winum JY, Peyron JF.

Leuk Lymphoma. 2018 Feb;59(2):460-468. doi: 10.1080/10428194.2017.1339875. Epub 2017 Jun 22.

PMID:
28641473
9.

NF-κB in Hematological Malignancies.

Imbert V, Peyron JF.

Biomedicines. 2017 May 31;5(2). pii: E27. doi: 10.3390/biomedicines5020027. Review.

10.

Iron chelation: an adjuvant therapy to target metabolism, growth and survival of murine PTEN-deficient T lymphoma and human T lymphoblastic leukemia/lymphoma.

Benadiba J, Rosilio C, Nebout M, Heimeroth V, Neffati Z, Popa A, Mary D, Griessinger E, Imbert V, Sirvent N, Peyron JF.

Leuk Lymphoma. 2017 Jun;58(6):1433-1445. doi: 10.1080/10428194.2016.1239257. Epub 2016 Oct 13.

PMID:
27736268
11.

Structure-function insights reveal the human ribosome as a cancer target for antibiotics.

Myasnikov AG, Kundhavai Natchiar S, Nebout M, Hazemann I, Imbert V, Khatter H, Peyron JF, Klaholz BP.

Nat Commun. 2016 Sep 26;7:12856. doi: 10.1038/ncomms12856.

12.

Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy.

Moschoi R, Imbert V, Nebout M, Chiche J, Mary D, Prebet T, Saland E, Castellano R, Pouyet L, Collette Y, Vey N, Chabannon C, Recher C, Sarry JE, Alcor D, Peyron JF, Griessinger E.

Blood. 2016 Jul 14;128(2):253-64. doi: 10.1182/blood-2015-07-655860. Epub 2016 Jun 2.

PMID:
27257182
13.

Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia Patients.

Griessinger E, Anjos-Afonso F, Vargaftig J, Taussig DC, Lassailly F, Prebet T, Imbert V, Nebout M, Vey N, Chabannon C, Filby A, Bollet-Quivogne F, Gribben JG, Peyron JF, Bonnet D.

Cancer Res. 2016 Apr 15;76(8):2082-6. doi: 10.1158/0008-5472.CAN-15-2063. Epub 2016 Mar 9.

14.

Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study.

Aubin F, Avenel-Audran M, Jeanmougin M, Adamski H, Peyron JL, Marguery MC, Léonard F, Puyraveau M, Viguier M; Société Française de Photodermatologie.

J Am Acad Dermatol. 2016 Mar;74(3):574-5. doi: 10.1016/j.jaad.2015.11.021. No abstract available.

PMID:
26892659
15.

Nuclear factor-κB regulates βAPP and β- and γ-secretases differently at physiological and supraphysiological Aβ concentrations.

Chami L, Buggia-Prévot V, Duplan E, Del Prete D, Chami M, Peyron JF, Checler F.

J Biol Chem. 2015 Dec 11;290(50):29758. doi: 10.1074/jbc.A115.333054. No abstract available.

16.

The Saccharomyces boulardii CNCM I-745 strain shows protective effects against the B. anthracis LT toxin.

Pontier-Bres R, Rampal P, Peyron JF, Munro P, Lemichez E, Czerucka D.

Toxins (Basel). 2015 Oct 30;7(11):4455-67. doi: 10.3390/toxins7114455.

17.

Reconciling Environment and Production in Managed Ecosystems: Is Ecological Intensification a Solution?

Cordonnier T, Peyron JL.

Environ Manage. 2015 Nov;56(5):1035-8. doi: 10.1007/s00267-015-0608-8. Epub 2015 Sep 10. No abstract available.

PMID:
26359193
18.

No major effect of cyclosporin A in patients with severe solar urticaria: a french retrospective case series.

Hurabielle C, Bedane C, Avenel-Audran M, Adamski H, Aubin F, Jeanmougin M, Marguery MC, Peyron JL, Poreaux C, Schmutz JL, Viguier M.

Acta Derm Venereol. 2015 Nov;95(8):1030-1. doi: 10.2340/00015555-2140. No abstract available.

19.

The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells.

Mourgues L, Imbert V, Nebout M, Colosetti P, Neffati Z, Lagadec P, Verhoeyen E, Peng C, Duprez E, Legros L, Rochet N, Maguer-Satta V, Nicolini FE, Mary D, Peyron JF.

Leukemia. 2015 Oct;29(10):1993-2002. doi: 10.1038/leu.2015.112. Epub 2015 Apr 30.

PMID:
25925206
20.

L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia.

Rosilio C, Nebout M, Imbert V, Griessinger E, Neffati Z, Benadiba J, Hagenbeek T, Spits H, Reverso J, Ambrosetti D, Michiels JF, Bailly-Maitre B, Endou H, Wempe MF, Peyron JF.

Leukemia. 2015 Jun;29(6):1253-66. doi: 10.1038/leu.2014.338. Epub 2014 Dec 8.

PMID:
25482130
21.

Saccharomyces boulardii modifies Salmonella typhimurium traffic and host immune responses along the intestinal tract.

Pontier-Bres R, Munro P, Boyer L, Anty R, Imbert V, Terciolo C, André F, Rampal P, Lemichez E, Peyron JF, Czerucka D.

PLoS One. 2014 Aug 13;9(8):e103069. doi: 10.1371/journal.pone.0103069. eCollection 2014.

22.

Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemia.

Rosilio C, Ben-Sahra I, Bost F, Peyron JF.

Cancer Lett. 2014 May 1;346(2):188-96. doi: 10.1016/j.canlet.2014.01.006. Epub 2014 Jan 22. Review.

PMID:
24462823
23.

The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells.

Rosilio C, Lounnas N, Nebout M, Imbert V, Hagenbeek T, Spits H, Asnafi V, Pontier-Bres R, Reverso J, Michiels JF, Sahra IB, Bost F, Peyron JF.

Cancer Lett. 2013 Aug 9;336(1):114-26. doi: 10.1016/j.canlet.2013.04.015. Epub 2013 Apr 21.

PMID:
23612073
24.

Solar urticaria: a time-extended retrospective series of 61 patients and review of literature.

Du-Thanh A, Debu A, Lalheve P, Guillot B, Dereure O, Peyron JL.

Eur J Dermatol. 2013 Apr 1;23(2):202-7. doi: 10.1684/ejd.2013.1933. Review.

PMID:
23587746
25.

Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas.

Lounnas N, Rosilio C, Nebout M, Mary D, Griessinger E, Neffati Z, Chiche J, Spits H, Hagenbeek TJ, Asnafi V, Poulsen SA, Supuran CT, Peyron JF, Imbert V.

Cancer Lett. 2013 Jun 1;333(1):76-88. doi: 10.1016/j.canlet.2013.01.020. Epub 2013 Jan 21.

PMID:
23348702
26.

Nuclear factor-κB regulates βAPP and β- and γ-secretases differently at physiological and supraphysiological Aβ concentrations.

Chami L, Buggia-Prévot V, Duplan E, Del Prete D, Chami M, Peyron JF, Checler F.

J Biol Chem. 2012 Jul 13;287(29):24573-84. doi: 10.1074/jbc.M111.333054. Epub 2012 May 31. Erratum in: J Biol Chem. 2013 Jul 5;288(27):19645. J Biol Chem. 2015 Dec 11;290(50):29758. Delprete, Dolores [corrected to Del Prete, Dolores].

27.

Modification of Salmonella Typhimurium motility by the probiotic yeast strain Saccharomyces boulardii.

Pontier-Bres R, Prodon F, Munro P, Rampal P, Lemichez E, Peyron JF, Czerucka D.

PLoS One. 2012;7(3):e33796. doi: 10.1371/journal.pone.0033796. Epub 2012 Mar 19.

28.

Calpain 2-dependent IκBα degradation mediates CPT-11 secondary resistance in colorectal cancer xenografts.

Fenouille N, Grosso S, Yunchao S, Mary D, Pontier-Bres R, Imbert V, Czerucka D, Caroli-Bosc FX, Peyron JF, Lagadec P.

J Pathol. 2012 May;227(1):118-29. doi: 10.1002/path.3034. Epub 2012 Feb 9.

PMID:
22069124
29.

Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS).

Ohanna M, Giuliano S, Bonet C, Imbert V, Hofman V, Zangari J, Bille K, Robert C, Bressac-de Paillerets B, Hofman P, Rocchi S, Peyron JF, Lacour JP, Ballotti R, Bertolotto C.

Genes Dev. 2011 Jun 15;25(12):1245-61. doi: 10.1101/gad.625811. Epub 2011 Jun 6.

30.

Solar urticaria treated with intravenous immunoglobulins.

Adamski H, Bedane C, Bonnevalle A, Thomas P, Peyron JL, Rouchouse B, Cambazard F, Jeanmougin M, Viguier M.

J Am Acad Dermatol. 2011 Aug;65(2):336-340. doi: 10.1016/j.jaad.2010.05.040. Epub 2011 Apr 22.

PMID:
21514688
31.

Octocrylene, an emerging photoallergen.

Avenel-Audran M, Dutartre H, Goossens A, Jeanmougin M, Comte C, Bernier C, Benkalfate L, Michel M, Ferrier-Lebouëdec MC, Vigan M, Bourrain JL, Outtas O, Peyron JL, Martin L.

Arch Dermatol. 2010 Jul;146(7):753-7. doi: 10.1001/archdermatol.2010.132.

PMID:
20644036
32.

Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection.

Martins FS, Dalmasso G, Arantes RM, Doye A, Lemichez E, Lagadec P, Imbert V, Peyron JF, Rampal P, Nicoli JR, Czerucka D.

PLoS One. 2010 Jan 27;5(1):e8925. doi: 10.1371/journal.pone.0008925.

33.

NF-kappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants.

Lounnas N, Frelin C, Gonthier N, Colosetti P, Sirvent A, Cassuto JP, Berthier F, Sirvent N, Rousselot P, Dreano M, Peyron JF, Imbert V.

Int J Cancer. 2009 Jul 15;125(2):308-17. doi: 10.1002/ijc.24294.

34.

[Treatment of connective tissue disorder-related acral syndromes using UVA-1 phototherapy. An open study of 11 cases].

Comte C, Bessis D, Picot E, Peyron JL, Guillot B, Dereure O.

Ann Dermatol Venereol. 2009 Apr;136(4):323-9. doi: 10.1016/j.annder.2008.12.022. Epub 2009 Mar 17. French.

PMID:
19361698
35.

Preclinical targeting of NF-kappaB and FLT3 pathways in AML cells.

Griessinger E, Frelin C, Cuburu N, Imbert V, Dageville C, Hummelsberger M, Sirvent N, Dreano M, Peyron JF.

Leukemia. 2008 Jul;22(7):1466-9. doi: 10.1038/sj.leu.2405102. Epub 2008 Jan 31. No abstract available.

PMID:
18239622
36.

Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.

Piche T, Saint-Paul MC, Dainese R, Marine-Barjoan E, Iannelli A, Montoya ML, Peyron JF, Czerucka D, Cherikh F, Filippi J, Tran A, Hébuterne X.

Gut. 2008 Apr;57(4):468-73. doi: 10.1136/gut.2007.127068. Epub 2008 Jan 14.

PMID:
18194987
37.

Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells.

Lagadec P, Griessinger E, Nawrot MP, Fenouille N, Colosetti P, Imbert V, Mari M, Hofman P, Czerucka D, Rousseau D, Berard E, Dreano M, Peyron JF.

Br J Cancer. 2008 Jan 29;98(2):335-44. doi: 10.1038/sj.bjc.6604082. Epub 2008 Jan 8.

38.

Inhibition of the NF-kappaB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-kappaB essential modulator NEMO.

Frelin C, Imbert V, Bottero V, Gonthier N, Samraj AK, Schulze-Osthoff K, Auberger P, Courtois G, Peyron JF.

Cell Death Differ. 2008 Jan;15(1):152-60. Epub 2007 Oct 12.

39.

[UVA-1 phototherapy: properties and indications].

Comte C, Picot E, Peyron JL, Dereure O, Guillot B.

Ann Dermatol Venereol. 2007 Apr;134(4 Pt 1):407-15. Review. French. No abstract available.

PMID:
17483769
40.

AS602868, a dual inhibitor of IKK2 and FLT3 to target AML cells.

Griessinger E, Imbert V, Lagadec P, Gonthier N, Dubreuil P, Romanelli A, Dreano M, Peyron JF.

Leukemia. 2007 May;21(5):877-85. Epub 2007 Mar 1.

PMID:
17330097
41.

Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes.

Dalmasso G, Cottrez F, Imbert V, Lagadec P, Peyron JF, Rampal P, Czerucka D, Groux H, Foussat A, Brun V.

Gastroenterology. 2006 Dec;131(6):1812-25. Erratum in: Gastroenterology. 2007 Apr;132(4):1637. Foussat, Arnaud [added]; Brun, Valerie [added].

PMID:
17087945
42.

[Polymorphic light eruption: prophylaxis using a topical combination of antioxidants and UVA protection formulations].

Jeanmougin M, Peyron JL, Thomas P, Beani JC, Guez E, Bachot N.

Ann Dermatol Venereol. 2006 May;133(5 Pt 1):425-8. French.

PMID:
16760827
43.

NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment.

Magné N, Toillon RA, Bottero V, Didelot C, Houtte PV, Gérard JP, Peyron JF.

Cancer Lett. 2006 Jan 18;231(2):158-68. Review.

PMID:
16399220
44.

Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival.

Cochet O, Frelin C, Peyron JF, Imbert V.

Cell Signal. 2006 Apr;18(4):449-55. Epub 2005 Jun 20.

PMID:
15967637
45.

[Photodistributed cutaneous drug reaction induced by proton pump inhibitors].

Raison-Peyron N, Minh HB, Peyron JL, Demoly P, Guillot B.

Therapie. 2005 Jan-Feb;60(1):85-7. French. No abstract available.

PMID:
15929479
46.

[The prospective multicenter study on standard photopatch tests by the French Society of Photodermatology from 1991-2001].

Leonard F, Adamski H, Bonnevalle A, Bottlaender A, Bourrain JL, Goujon-Henry C, Leroy D, Manciet JR, Marguery MC, Peyron JL, Plantin P, Roger H, Schmutz JL, Terrier G, Vigan M, Bernard P.

Ann Dermatol Venereol. 2005 Apr;132(4):313-20. French.

PMID:
15886557
47.

[Narrow band UVB phototherapy in the treatment of widespread lichen planus].

Habib F, Stoebner PE, Picot E, Peyron JL, Meynadier J, Meunier L.

Ann Dermatol Venereol. 2005 Jan;132(1):17-20. French.

PMID:
15746601
48.

NF-kappaB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death.

Thyss R, Virolle V, Imbert V, Peyron JF, Aberdam D, Virolle T.

EMBO J. 2005 Jan 12;24(1):128-37. Epub 2004 Dec 16.

49.

[Biomodulation of transcriptional factor NF-kappa B by ionizing radiation].

Magné N, Didelot C, Toillon RA, Van Houtte P, Peyron JF.

Cancer Radiother. 2004 Oct;8(5):315-21. Review. French.

PMID:
15561597
50.

Targeting NF-kappaB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells.

Frelin C, Imbert V, Griessinger E, Peyron AC, Rochet N, Philip P, Dageville C, Sirvent A, Hummelsberger M, Bérard E, Dreano M, Sirvent N, Peyron JF.

Blood. 2005 Jan 15;105(2):804-11. Epub 2004 Sep 28.

PMID:
15454494

Supplemental Content

Loading ...
Support Center